FDA-Drug2026-06-24Class IIPROCESSING DEFECT
Med Pride Hydrocortisone Cream 1% recalled for manufacturing quality deficiencies
OTHERNationwide distribution
Med Pride Hydrocortisone Cream recalled for quality deficiencies
The FDA found manufacturing quality control problems (CGMP deviations) during an inspection of the facility that makes Med Pride Hydrocortisone Cream 1%. Multiple lots of the product are affected. No injuries have been reported.
- Check if you have Med Pride Hydrocortisone Cream 1% in the 16 oz tube size, particularly lots 003–064.
- Contact your pharmacy or healthcare provider if you have questions about whether your specific tube is affected.
- Do not use the product if you have one of the affected lots; return it to where you bought it or contact Shield Line LLC at the address on the package.
Hazard
CGMP Deviations; deficiencies observed during FDA inspection
Sold states
US Nationwide.
Affected count
4,738 tubes
Manufactured in
225 - 4 - 1 Saily Village, Survey No, Dadra And Nagar Haveli, India
Products
Med Pride, HYDROCORTISONE CREAM 1%, Net Wt. 16oz (454g) tubes, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 52410 305061.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0639-2026More Dabur India Limited recalls
- FDA-Drug2026-06-24Med Pride Hydrocortisone Cream 1% recalled for manufacturing deficiencies
- FDA-Drug2026-06-24Rapidol Triple Antibiotic First Aid Ointment recalled for manufacturing deficiencies
- FDA-Drug2026-06-24Med Pride Triple Antibiotic Ointment recalled for manufacturing quality deficiencies
- FDA-Drug2026-06-24Lucky Super Soft First Aid Triple Antibiotic Ointment recalled for manufacturing deficiencies
- FDA-Drug2026-06-24Lucky Super Soft Antifungal Athlete's Foot Cream recalled for manufacturing deficiencies
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief